Return to Article Details ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS GLYCOPROTEIN 160 AS A VACCINE CANDIDATE FOR B CELL EPITOPE OF ACQUIRED IMMUNODEFICIENCY SYNDROME Download Download PDF